Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Maintaining momentum mid month requires steady approaches. Discover ways to keep your budget on track mid month and stay aligned with goals.
25,694 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
When a hedge fund disclosed a sizable new stake in Asbury Automotive, the market reacted. This guide breaks down why ...
Grail stock faced another sharp move as trial news weighed on sentiment. This guide unpacks why the slump happened, w...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
A perplexing Friday drop in Coca-Cola stock raised questions about cybersecurity, earnings risk, and how to react to ...
What if a $1,000 bet on COSTCO in 2006 rode all the way to today? This article breaks down the math, compares it to t...
An in-depth, grounded analysis of MDU Resources' Q1 2026 earnings call. Learn what to watch, how to model the numbers...
When a COO sells a hefty block of stock as the market rewards the company with an big run, investors should look beyo...
Could a bold thesis around Oklo Inc. unlock life-changing gains? This forward-looking guide breaks down why nuclear e...
A 64-year-old non-spouse heir faces a looming 10-year distribution window after inheriting a $750,000 traditional IRA...
A landmark move in AI memory supply, hynix's billion nasdaq listing could open U.S. access to SK Hynix. This guide ex...
When a chief financial officer liquidates shares, investors pay attention. This article digs into maplight's just sol...